ARTICLE | Company News
Amgen submits additional Kineret data
April 23, 2001 7:00 AM UTC
AMGN submitted additional data to the FDA for its BLA for Kineret anakinra (IL-1ra) to treat rheumatoid arthritis. AMGN Senior Director of Product Development Robert Baltera told BioCentury that the a...